• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The efficancy of YC-1 transarterial chemoembolization besed on hypoxia response

Research Project

Project/Area Number 26860968
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Radiation science
Research InstitutionHirosaki University

Principal Investigator

fujita hiromasa  弘前大学, 医学部附属病院, 医員 (30720742)

Research Collaborator TAKAI Yoshihiro  一般財団法人 脳神経疾患研究所, 南東北BNCT研究センター, センター長
SATOU Mariko  弘前大学, 大学院医学研究科, 助教
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords低酸素 / 肝細胞癌 / 低酸素細胞
Outline of Final Research Achievements

Previous studies reported that cancer cell get theraputic resistance in hypoxia. Hepatocellular carcinoma has same report.In this study,we investigated the efficancy ofcombination of YC-1 and drug eluting beads.We could not find good conditions of
conbination of these. On the other hand, we investigated other drug.We find that metformin improve theraputic resistance of hepatocellular carcinom in hypoxia.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi